Premium
Gossamer Bio Inc (GOSS)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Show more
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
- $327 Million in Cash, Cash Equivalents & Marketable Securities, as of September 30, 2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0072 | -1.02857142857 | 0.7 | 0.7314 | 0.6801 | 981434 | 0.71625153 | CS |
| 4 | -0.1878 | -21.3263683852 | 0.8806 | 0.9158 | 0.6617 | 1136958 | 0.75070054 | CS |
| 12 | -0.2172 | -23.8681318681 | 0.91 | 1.11 | 0.6617 | 920267 | 0.87802305 | CS |
| 26 | 0.1128 | 19.4482758621 | 0.58 | 1.37 | 0.4993 | 1466241 | 0.86061284 | CS |
| 52 | -0.1369 | -16.4999397373 | 0.8297 | 1.6 | 0.4993 | 1461976 | 0.92146518 | CS |
| 156 | -9.6572 | -93.3062801932 | 10.35 | 15.195 | 0.4525 | 1997915 | 3.03381798 | CS |
| 260 | -24.7472 | -97.2767295597 | 25.44 | 27.1497 | 0.4525 | 1435694 | 4.4778827 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
